CN106267049A - A kind of medicine treating obesity - Google Patents
A kind of medicine treating obesity Download PDFInfo
- Publication number
- CN106267049A CN106267049A CN201510265622.1A CN201510265622A CN106267049A CN 106267049 A CN106267049 A CN 106267049A CN 201510265622 A CN201510265622 A CN 201510265622A CN 106267049 A CN106267049 A CN 106267049A
- Authority
- CN
- China
- Prior art keywords
- obesity
- parts
- medicine
- radix
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of medicine treating obesity, be made up of the raw material of following weight proportioning: Radix Astragali 12-18 part, Rhizoma Atractylodis Macrocephalae 12-18 part, Rhizoma Zingiberis Recens 4-8 part, Radix Stephaniae Tetrandrae 4-8 part, Radix Glycyrrhizae Preparata 4-8 part, Fructus Jujubae 4-8 part.The present invention treats the medicine of obesity and chooses 6 kinds of natural Chinese medicine compatibilities, and each crude drug synergism plays the effects such as tonifying Qi and lifting yang, invigorating the spleen and benefiting QI, dampness diuretic, benefiting qi and nourishing yin, invigorating the spleen and regulating the stomach, treating both the principal and the secondary aspects of a disease at the same time, and to treating, obesity is effective, has no side effect.And its preparation method is simple, the course for the treatment of is shorter, taking convenience, low cost, effective percentage reaches more than 80%.
Description
Technical field
The present invention relates to Chinese medicine, a kind of medicine treating obesity.
Background technology
Obesity is one group of common, ancient metabolism disease group.When human body feed heat is more than consumption of calorie, waste heat is with storage as fat in internal, and its amount exceedes normal physiological requirement, and then develops into obesity when reaching certain value.The 15%～18% of Normal Male Adults adipose tissue mass about percentage of liveweight, women accounts for 20%～25%.Increasing with the age, body fat proportion increases accordingly.Because body fat increase makes be above standard body weight 20% or Body Mass Index [BMI=body weight (Kg)/(height) 2(m2)] of body weight be referred to as obesity more than 24.As the person of seeking simple obesity can be claimed without the obvious cause of disease；There is clear and definite cause of disease person and be referred to as secondary obesity.
Summary of the invention
It is an object of the invention to provide that a kind of good effect, the course for the treatment of be shorter, low cost, the medicine for the treatment of obesity that has no side effect.
The technical scheme realizing the object of the invention is:
A kind of medicine treating obesity, is made up of the raw material of following weight proportioning:
Radix Astragali 12-18 part, Rhizoma Atractylodis Macrocephalae 12-18 part, Rhizoma Zingiberis Recens 4-8 part, Radix Stephaniae Tetrandrae 4-8 part, Radix Glycyrrhizae Preparata 4-8 part, Fructus Jujubae 4-8 part.
Preferably, the optimum weight proportioning of each raw material is:
The Radix Astragali 15 parts, the Rhizoma Atractylodis Macrocephalae 15 parts, 6 parts of Rhizoma Zingiberis Recens, Radix Stephaniae Tetrandrae 6 parts, Radix Glycyrrhizae Preparata 6 parts, 6 parts of Fructus Jujubae.
Described crude drug is in shop of Chinese medicines and commercially available.
The preparation method of medicine of the present invention, can decoct into decoction according to a conventional method, method particularly includes: weigh each crude drug by weight ratio, add the water of 5-10 times of crude drug total amount, boil rear slow fire with big fire and boil 10-20 minute, filter and remove residue, to obtain final product.
Instructions of taking: three times a day, each 30 milliliters, general 15-20 day is the most effective.
Medicine of the present invention may be made as pill, powder or capsule.
In the present invention, effect of each crude drug is as follows:
The Radix Astragali: sweet in the mouth, slightly warm in nature, returns lung, spleen, liver, kidney channel.There is enhancing human body immunity function, tonifying Qi and lifting yang, inducing diuresis to remove edema, torr skin ulcer granulation promoting, protect the liver the effect that diuresis, defying age, anti-stress, blood pressure lowering are antibacterial.
The Rhizoma Atractylodis Macrocephalae: bitter in the mouth, sweet, warm.Return spleen, stomach warp.There is the effects such as invigorating the spleen and benefiting QI, dampness diuretic, strengthening superficial resistance to stop perspiration.
Rhizoma Zingiberis Recens: acrid in the mouth, cool in nature, returns spleen, lung meridian.There is effect of relieving the exterior syndrome by diaphoresis, warming middle-JIAO to arrest vomiting, warming the lung to relieve cough.
Radix Stephaniae Tetrandrae: acrid in the mouth, hardship, cold in nature, return bladder, lung meridian, there is wind-expelling pain-stopping, effect of inducing diuresis to remove edema.
Radix Glycyrrhizae Preparata: sweet in the mouth, warm in nature, return spleen, stomach, lung meridian.There is benefiting qi and nourishing yin, the multiple arteries and veins that activates yang, cushion toxicity, strong effect.
Fructus Jujubae: sweet in the mouth, warm in nature, returns spleen, stomach warp.There is the effects such as qi-restoratives QI invigorating, nourishing blood to tranquillize the mind, invigorating the spleen and regulating the stomach.
The present invention treats the medicine of obesity and chooses 6 kinds of natural Chinese medicine compatibilities, and each crude drug synergism plays the effects such as tonifying Qi and lifting yang, invigorating the spleen and benefiting QI, dampness diuretic, benefiting qi and nourishing yin, invigorating the spleen and regulating the stomach, treating both the principal and the secondary aspects of a disease at the same time, and to treating, obesity is effective, has no side effect.And its preparation method is simple, the course for the treatment of is shorter, taking convenience, low cost, effective percentage reaches more than 80%.
Detailed description of the invention
Below by embodiment, present invention is further described, but is not limitation of the invention.
Embodiment 1:
A kind of medicine treating obesity, the weight proportion of each raw material is:
The Radix Astragali 12 parts, the Rhizoma Atractylodis Macrocephalae 12 parts, 4 parts of Rhizoma Zingiberis Recens, Radix Stephaniae Tetrandrae 4 parts, Radix Glycyrrhizae Preparata 4 parts, 4 parts of Fructus Jujubae.Decoct into decoction oral according to a conventional method.
Embodiment 2:
A kind of medicine treating obesity, the weight proportion of each raw material is:
The Radix Astragali 15 parts, the Rhizoma Atractylodis Macrocephalae 15 parts, 6 parts of Rhizoma Zingiberis Recens, Radix Stephaniae Tetrandrae 6 parts, Radix Glycyrrhizae Preparata 6 parts, 6 parts of Fructus Jujubae.Decoct into decoction oral according to a conventional method.
Embodiment 3:
A kind of medicine treating obesity, the weight proportion of each raw material is:
The Radix Astragali 18 parts, the Rhizoma Atractylodis Macrocephalae 18 parts, 8 parts of Rhizoma Zingiberis Recens, Radix Stephaniae Tetrandrae 8 parts, Radix Glycyrrhizae Preparata 8 parts, 8 parts of Fructus Jujubae.Decoct into decoction oral according to a conventional method.
Experimental example:
In order to prove the clinical efficacy of medicine of the present invention further, select 30 example patients, the curative effect of medicine of the present invention is carried out clinical observation.
Efficacy determination is based on transference cure, and changes situation with reference to effect etc., is divided into effective, effective and invalid.
Effective: symptom substantially alleviates and effect is obviously improved.
Effective: symptom and effect have certain improvement.
Invalid: symptom and sign are all without improving or DeGrain.
Apply in Drug therapy obesity 30 example of the present invention, male 21 examples, female 9 example.Fundamental symptoms is: in the short time, body weight promptly increases, To Be Protected from Heat, mobility reduces, even movable time have slight tachypnea, activity after dyspnea, drowsiness, sleep time snoring, have with hypertension, diabetes, gout.After oral Drug therapy of the present invention, symptom all has certain improvement, the most effective 27 examples, effective 29 examples, invalid 1 example, effective percentage 96%.
Claims (2)
1. treat a medicine for obesity, it is characterized in that being made up of the raw material of following weight proportioning:
Radix Astragali 12-18 part, Rhizoma Atractylodis Macrocephalae 12-18 part, Rhizoma Zingiberis Recens 4-8 part, Radix Stephaniae Tetrandrae 4-8 part, Radix Glycyrrhizae Preparata 4-8 part, Fructus Jujubae 4-8 part.
Medicine the most according to claim 1, is characterized in that the weight proportion of each raw material is:
The Radix Astragali 15 parts, the Rhizoma Atractylodis Macrocephalae 15 parts, 6 parts of Rhizoma Zingiberis Recens, Radix Stephaniae Tetrandrae 6 parts, Radix Glycyrrhizae Preparata 6 parts, 6 parts of Fructus Jujubae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510265622.1A CN106267049A (en) | 2015-05-23 | 2015-05-23 | A kind of medicine treating obesity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510265622.1A CN106267049A (en) | 2015-05-23 | 2015-05-23 | A kind of medicine treating obesity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106267049A true CN106267049A (en) | 2017-01-04 |
Family
ID=57632741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510265622.1A Withdrawn CN106267049A (en) | 2015-05-23 | 2015-05-23 | A kind of medicine treating obesity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106267049A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108404071A (en) * | 2018-04-09 | 2018-08-17 | 北京科泰健业企业管理有限公司 | A kind of body shaping health care medicinal and its pill preparation method, application method |
| CN114832033A (en) * | 2022-05-25 | 2022-08-02 | 赵霞 | Traditional Chinese medicine composition with weight-losing effect and preparation method and application thereof |
-
2015
- 2015-05-23 CN CN201510265622.1A patent/CN106267049A/en not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108404071A (en) * | 2018-04-09 | 2018-08-17 | 北京科泰健业企业管理有限公司 | A kind of body shaping health care medicinal and its pill preparation method, application method |
| CN114832033A (en) * | 2022-05-25 | 2022-08-02 | 赵霞 | Traditional Chinese medicine composition with weight-losing effect and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102430092B (en) | Traditional Chinese medicine composite for treating stomach cold and stomachache | |
| CN103463587B (en) | A kind of Chinese medicine composition for the treatment of Deficiency and coldness of spleen and stomach | |
| CN103948708B (en) | A kind of Chinese medicine for the treatment of restless legs syndrome | |
| CN104857267A (en) | Traditional Chinese medicine for weight loss | |
| CN103893329A (en) | Pharmaceutical composition for treating irritable bowel syndrome | |
| CN106267049A (en) | A kind of medicine treating obesity | |
| CN103893613B (en) | A kind of medicine treating oral ulcer and preparation method | |
| CN106109690A (en) | Medicine for the alopecia that treatment is caused by deficiency of the liver and kindey | |
| CN103920089A (en) | Traditional Chinese medicinal composition for treating climacteric syndrome | |
| CN104474428B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of spinal cord injury | |
| CN104173897B (en) | Treat the Chinese medicine composition of the menopausal syndrome as caused by ovarian failure | |
| CN103948707B (en) | A kind of Chinese medicine for the treatment of restless legs syndrome | |
| CN103611140B (en) | A kind of foot bath formula of Cure for insomnia | |
| CN105362995A (en) | Traditional Chinese medicine for treating damp abundance disturbing spleen syndrome type somnolence | |
| CN106110008A (en) | A kind of Chinese medicine preparation treating postpartum depression and preparation method | |
| CN102048956A (en) | Medicinal liquor | |
| CN105232749A (en) | Traditional Chinese medicine mixture with functions of kidney tonifying, Yang strengthening, Qi replenishing and spleen invigorating | |
| CN100534468C (en) | Orally-administered traditional Chinese medicine for treating irritable bowel syndrome | |
| CN103877226B (en) | Bean curd Monopterus albus (Zuiew) gruel with nourishing liver and kidney effect and preparation method thereof | |
| CN104689239A (en) | Traditional Chinese medicine composition for treating cholelithiasis and preparation method thereof | |
| CN104587251B (en) | A kind of Chinese medicinal capsule and preparation method thereof for treating gout | |
| CN103990019A (en) | Traditional Chinese medicine preparation for treating light-headedness | |
| CN103494900A (en) | Traditional Chinese medicine for treating stiff neck | |
| CN103623270B (en) | A kind of Chinese medicine for the treatment of spleen deficiency type fever | |
| CN102335314B (en) | Chinese medicinal composition for treating stomach diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C04 | Withdrawal of patent application after publication (patent law 2001) | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170104 |